1000027307. jpg
Off-Plan|
Erstverkauf
Grundrisse
Karte
8
AED625.000
Geschätzte Zahlung AED 2,6 Tsd./Monat
Finanzierung prüfen
BlueBell Residence, Al Amerah, Ajman
1 Schlafzimmer
2 Bäder
109 m²

Wohnung in Al Amerah,BlueBell Residence, 1 schlafzimmer, 625000 AED - 16681730

Bluebell Residence – Premium Freehold Living in Al Amra, Ajman
Discover refined living at Bluebell Residence, a modern residential masterpiece located in the prime area of Al Amra, Ajman. Designed for comfort, elegance, and long-term investment value, Bluebell offers more than just a home — it delivers a complete lifestyle experience.

Whether you are an end-user or investor, this project combines contemporary design, premium facilities, and a flexible payment plan to suit your needs.

Property Features
Spacious luxury apartments with modern layouts
Elegant living areas with high-quality finishes
Closed kitchens with practical design
Built-in wardrobes for smart storage
Fully equipped health club with latest fitness facilities
Retail shops within the building for daily convenience
100% Freehold ownership for all nationalities
No commission fees

Prime Location – Al Amra, Ajman
15 minutes to Ajman Beach
20 minutes to Amina Hospital
3 minutes to Al Hamidiya Park
Easy access to main highways connecting to Sharjah & Dubai

Flexible 7-Year Payment Plan
Affordable initial down payment
Easy monthly installments up to 7 years
Investor-friendly structure

Objektinformationen

  • TypWohnung
  • ZweckVerkauf
  • Referenznr.Bayut - 104997-nDK1Ae
  • FertigstellungOff-Plan
  • Hinzugefügt am29. September 2026
  • ÜbergabedatumQ4 2026

Validierte Informationen

Validated Check Mark Icon

Grundrisse

3D Live

3D-Bild

2D-Bild

  • Unit 17,19,21
    Unit 17,19,21

Hypothek

Berechne und sieh dir die monatliche Hypothek für diese Wohnung an

Gebäudeinformationen

Validated Check Mark Icon

Merkmale / Ausstattung

Balkon oder Terrasse
Schwimmbad
Notstromversorgung
Zentralklimaanlage
+ 15 weitere Ausstattungen

Projektinformationen

Validated Check Mark Icon

Trends & Indizes

Regulatorische Informationen

Für Sie empfohlen